Manufacturer:

Athenex Pharmaceuticals

Name:

Cyclophosphamide

Category:

J Code

HCPCS:

J9070

NDC(s):

00781-3233-94, 00781-3244-94, 00781-3255-94, 10019-0935-01, 10019-0936-01, 10019-0937-01, 10019-0938-01, 10019-0939-01, 10019-0942-01, 10019-0943-01, 10019-0944-01, 10019-0945-01, 10019-0955-01, 10019-0956-01, 10019-0957-01, 16714-0857-01, 16714-0858-01, 16714-0859-01, 50742-0519-02, 50742-0520-05, 50742-0521-10, 68001-0442-26, 68001-0443-27, 68001-0444-32, 68001-0564-22, 68001-0565-28, 70121-1238-01, 70121-1239-01, 70121-1240-01, 70860-0218-03, 70860-0218-05, 72572-0083-01, 72572-0085-01, 72572-0087-01, 72603-0104-01, 72603-0326-01, 70860-0218-10,

Primary Type:

Cancer

Route of Administration:

Intravenous

About:

Cyclophosphamide is a Cancer drug manufactured by Athenex Pharmaceuticals and administered via the Intravenous route of administration. The J Code: J9070 is aligned to the drug Cyclophosphamide.